
Site of Neuroendocrine Tumors Affects Outcomes With Cabozantinib
Jennifer Chan, MD, MPH, clinical director at the Gastrointestinal Cancer Center and director for the Program in Carcinoid and Neuroendocrine Tumors at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School, discussed …